ArticleBMJ open2025

Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol.

Xiankun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.